Jonathan Paolino, MD

Physician, Department of Pediatric Oncology
Instructor of Pediatrics, Harvard Medical School
Faceless Avatar - Male
Fax 617-632-4410
NPI 1205217718
Print Profile
Request an Appointment
Locations

Jonathan Paolino, MD

Physician, Department of Pediatric Oncology
Instructor of Pediatrics, Harvard Medical School

Medical Services

Programs & Services
Cancer and Blood Disorders Center
Conditions & Treatments
Langerhans Cell Histiocytosis
Leukemia
Lymphoblastic Lymphoma
Pediatric and Childhood Cancers
Education
Undergraduate School
College of the Holy Cross
Worcester
MA
Medical School
University of Massachusetts at Worcester
Worcester
MA
Internship
Pediatrics
Massachusetts General Hospital
Boston
MA
Residency
Pediatrics
Massachusetts General Hospital
Boston
MA
Fellowship
Pediatric Oncology
Dana-Farber Cancer Institute/Boston Children's Hospital
Boston
MA

Publications

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study. View Abstract
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen. View Abstract
Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative. View Abstract
Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress. View Abstract
IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. View Abstract
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. View Abstract
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia. View Abstract
Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure. View Abstract
Simulated Umbilical Venous Catheter Placement Improves Resident Competence and Confidence. View Abstract
Peripheral blood smears of children with multisystem inflammatory syndrome demonstrate prominence of early myeloid forms with morphologic evidence of toxic change. View Abstract
Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia. View Abstract
The Massachusetts General Hospital Guide to Medical Care in Patients with Autism Spectrum Disorder View Abstract
Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results. View Abstract
Usefulness of pancreatitis-associated protein, a novel biomarker, to predict severity of disease in ambulatory patients with heart failure. View Abstract
J Crohns Colitis View Abstract
Inflammatory Bowel Diseases View Abstract
Locations